{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:05:27Z","timestamp":1787162727796,"version":"build-2736575974"},"reference-count":16,"publisher":"Japanese Society of Toxicology","issue":"Special","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2009]]},"DOI":"10.2131\/jts.34.s167","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T02:04:33Z","timestamp":1237428273000},"page":"S167-S174","source":"Crossref","is-referenced-by-count":11,"title":["Collaborative work on evaluation of ovarian toxicity 16) Effects of 2 or 4 weeks repeated dose studies and fertility study of Chlorpromazine hydrochloride in rats"],"prefix":"10.2131","volume":"34","author":[{"given":"Yuko","family":"Izumi","sequence":"first","affiliation":[{"name":"Development Research Center, Takeda Pharmaceutical Company Limited"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Development Research Center, Takeda Pharmaceutical Company Limited"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Awasaki","sequence":"additional","affiliation":[{"name":"Development Research Center, Takeda Pharmaceutical Company Limited"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hikawa","sequence":"additional","affiliation":[{"name":"Development Research Center, Takeda Pharmaceutical Company Limited"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Minagi","sequence":"additional","affiliation":[{"name":"Development Research Center, Takeda Pharmaceutical Company Limited"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Chatani","sequence":"additional","affiliation":[{"name":"Development Research Center, Takeda Pharmaceutical Company Limited"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","unstructured":"Barraclough, C.A. (1992): Neural control of the synthesis and release of luteinizing hormone-releasing hormone. Ciba Found. Symp., <b>168<\/b>, 233-251."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Barraclough, C.A. and Wise, P.M. (1982): The role of catecholamines in the regulation of pituitary luteinizing hormone and follicle-stimulating hormone secretion. Endocr. Rev., <b>3<\/b>, 91-119.","DOI":"10.1210\/edrv-3-1-91"},{"key":"3","unstructured":"Baldessarini, R.J. (1985): Drug and the treatment of psychiatric disorders. In Goodman and Gilman's The pharmacological basis of therapeutics. (Gilman, A.G., Goodman, L.S., Rall, T.W. and Murad, F., ed.), pp. 391-447. Macmillan, New York."},{"key":"4","unstructured":"B&uuml;rki, H.R., Ruch, W., Asper, H., Baggiolini, M. and Stille, G. (1974): Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat. Eur. J. Pharmacol., <b>27<\/b>, 180-190."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Everett, J.W. and Tyrey, L. (1982): Similarity of luteinizing hormone surges induced by medial preoptic stimulation in female rats blocked with pentobarbital, morphine, chlorpromazine, or atropine. Endocrinology, <b>111<\/b>, 1979-1985.","DOI":"10.1210\/endo-111-6-1979"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90793-4"},{"key":"7","unstructured":"Kuew-Hsiung, L.U., Amenomori, Y., Chen, C.L. and Meites, J. (1970): Effects of central acting drugs on serum and pituitary prolactin levels in rats. Endocrinology, <b>87<\/b>, 667-672."},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(95)00049-J"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Lucas, J.N., Rudmann, D.G., Credille, K.M., Irizarry, A.R., Peter, A. and Snyder, P.W. (2007): The rat mammary gland: morphologic changes as an indicator of systemic hormonal perturbations induced by xenobiotics. Toxicol. Pathol., <b>35<\/b>, 199-207.","DOI":"10.1080\/01926230601156260"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Nakahara, T., Hirano, M., Uchimura, H., Saito, M., Kim, J.S., Matsumoto, T., Yokoo, H., Shimomura, M. and Mukai, A. (1983): Dopamine, serotonin and alpha-adrenergic receptor blocking activities in serum and their relationships to prolactin level in schizophrenic patients receiving long-term chlorpromazine treatment. Psychopharmacology (Berlin, Ger.), <b>79<\/b>, 266-270.","DOI":"10.1007\/BF00427825"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1530\/jrf.0.0170555"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Polisseni, F., Faletti, A.G., Pereira V.M., Reis, A.M. Camargos, A.F. and Reis, F.M. (2005): Prolactin inhibits oocyte release after gonadotropin stimulation in the rat: putative mechanism involving ovarian production of beta-endorphin and prostaglandin. Fertil. Steril., <b>83<\/b>, 1119-1124.","DOI":"10.1016\/j.fertnstert.2004.07.981"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Saigo, K. (1990): Inhibitory effect of chlorpromazine on rat reproduction: a test of administration for nine weeks before breeding. Reprod. Toxicol., <b>4<\/b>, 29-36.","DOI":"10.1016\/0890-6238(90)90076-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Seeman, P. and Van Tol, H.H. (1994): Dopamine receptor pharmacology. Trend Pharmacol. Sci., <b>15<\/b>, 264-270.","DOI":"10.1016\/0165-6147(94)90323-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Taya, K., Sato, T. and Igarashi, M. (1975): Effect of prostaglandin F2&alpha; upon ovulation and LH, FSH and prolactin secretion in chlorpromazine blocked rats. Endocrinol. Japon., <b>22<\/b>, 131-136.","DOI":"10.1507\/endocrj1954.22.131"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Yokota, H. (1990): Inhibitory effect of chlorpromazine on rat reproduction: a two week administration test before mating. J. Toxicol. Sci., <b>15<\/b>, 15-28.","DOI":"10.2131\/jts.15.15"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jts\/34\/Special\/34_Special_SP167\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:26:14Z","timestamp":1620948374000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jts\/34\/Special\/34_Special_SP167\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":16,"journal-issue":{"issue":"Special","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.34.s167","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}